Bacterial actin assembly requires toca-1 to relieve N-wasp autoinhibition

Cell Host & Microbe
Yiuka LeungM B Goldberg

Abstract

Actin polymerization in the mammalian cytosol can be locally activated by mechanisms that relieve the autoinhibited state of N-WASP, an initiator of actin assembly, a process that also requires the protein Toca-1. Several pathogenic bacteria, including Shigella, exploit this host feature to infect and disseminate efficiently. The Shigella outer membrane protein IcsA recruits N-WASP, which upon activation at the bacterial surface mediates localized actin polymerization. The molecular role of Toca-1 in N-WASP activation during physiological or pathological actin assembly processes in intact mammalian cells remains unclear. We show that actin tail initiation by S. flexneri requires Toca-1 for the conversion of N-WASP from a closed inactive conformation to an open active one. While N-WASP recruitment is dependent on IcsA, Toca-1 recruitment is instead mediated by S. flexneri type III secretion effectors. Thus, S. flexneri independently hijacks two nodes of the N-WASP actin assembly pathway to initiate localized actin tail assembly.

References

May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M L BernardiniP J Sansonetti
Jul 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·M B Goldberg, J A Theriot
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·R D MullinsT D Pollard
Feb 9, 2000·The Journal of Cell Biology·J TauntonC A Larabell
May 2, 2001·Nature Cell Biology·N Martinez-QuilesN Ramesh
Sep 5, 2001·Molecular Microbiology·J R RobbinsJ A Theriot
Feb 19, 2002·The Journal of Biological Chemistry·Christophe BeloinCharles J Dorman
Feb 28, 2002·Current Biology : CB·Tomoyuki ShibataScott B Snapper
Apr 27, 2002·Cell Motility and the Cytoskeleton·Juana Magdalena, Marcia B Goldberg
Nov 5, 2003·The Journal of Experimental Medicine·Luisa M StammEric J Brown
Jan 30, 2004·Nature·Edith GouinPascale Cossart
Mar 11, 2004·Cellular Microbiology·Shabeen AllyMarcia B Goldberg
Jul 9, 2004·Cellular Microbiology·Robert L JengMatthew D Welch
Feb 8, 2005·Current Opinion in Microbiology·Edith GouinPascale Cossart
Aug 4, 2006·The Journal of Biological Chemistry·Tetsuhiro KakimotoManabu Negishi
Dec 1, 2006·Nature·Jorge E Galán, Hans Wolf-Watz

❮ Previous
Next ❯

Citations

Nov 20, 2008·Immunologic Research·Narayanaswamy Ramesh, Raif Geha
Oct 2, 2009·Nature Cell Biology·Stéphane Romero, Guy Tran Van Nhieu
May 1, 2012·The Journal of Biological Chemistry·Kenneth G CampelloneMatthew D Welch
Oct 21, 2009·Infection and Immunity·Jason E HeindlMarcia B Goldberg
Dec 12, 2012·Infection and Immunity·Ana-Maria DragoiHervé Agaisse
Mar 17, 2010·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Chihiro Sasakawa
Apr 19, 2011·Annual Review of Phytopathology·Brad DayChristopher J Staiger
Oct 5, 2011·The Journal of Cell Biology·Cat M Haglund, Matthew D Welch
Feb 24, 2016·Frontiers in Cellular and Infection Microbiology·Sina Krokowski, Serge Mostowy
Apr 22, 2009·Biochemical and Biophysical Research Communications·David A AdamovichScott B Snapper
Mar 26, 2016·Frontiers in Cellular and Infection Microbiology·Hervé Agaisse
Nov 6, 2012·Cellular Microbiology·Serge Mostowy
Dec 4, 2014·Cellular Microbiology·Cesar M Valencia-GallardoGuy Tran Van Nhieu
May 23, 2015·Frontiers in Immunology·Hiroshi AshidaChihiro Sasakawa
Mar 19, 2014·Gut Microbes·Ana-Maria Dragoi, Hervé Agaisse
Sep 17, 2013·Cell Host & Microbe·Matthew D Welch, Michael Way
Nov 21, 2014·PLoS Pathogens·Serge Mostowy
Aug 16, 2019·Cellular Microbiology·Céline MichardHervé Agaisse
Apr 4, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alan HuettRamnik J Xavier
Jun 30, 2010·Communicative & Integrative Biology·Robert FrickeSven Bogdan
Dec 10, 2020·Microorganisms·Waad BajunaidFrançois-Xavier Campbell-Valois
Jun 24, 2016·Microbiology Spectrum·Kevin Hybiske, Richard Stephens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.